$96.6 Million is the total value of PERKINS CAPITAL MANAGEMENT INC's 105 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 19.4% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
INUV | Buy | INUVO INC | $2,877,000 | +1.2% | 5,812,672 | +0.1% | 2.98% | +27.8% |
VCYT | Buy | VERACYTE INC | $2,550,000 | -24.8% | 128,130 | +4.2% | 2.64% | -5.0% |
AXGN | Buy | AXOGEN INC | $2,506,000 | +9.5% | 305,940 | +6.2% | 2.59% | +38.3% |
NTRA | Buy | NATERA INC | $2,293,000 | -3.5% | 64,700 | +10.8% | 2.37% | +21.9% |
QUIK | Buy | QUICKLOGIC CORP | $2,122,000 | +56.4% | 250,285 | +1.4% | 2.20% | +97.6% |
STRM | Buy | STREAMLINE HEALTH SOLUTIONS | $2,106,000 | -20.6% | 1,658,140 | +0.1% | 2.18% | +0.3% |
BTTR | Buy | BETTER CHOICE CO INC | $1,853,000 | +8.4% | 842,250 | +25.7% | 1.92% | +36.9% |
NEO | Buy | NEOGENOMICS INC | $1,651,000 | -10.9% | 202,550 | +32.8% | 1.71% | +12.5% |
CTLP | Buy | CANTALOUPE INC | $1,513,000 | -13.4% | 270,125 | +4.6% | 1.57% | +9.3% |
XGN | Buy | EXAGEN INC | $1,360,000 | -15.7% | 236,975 | +17.9% | 1.41% | +6.4% |
CDNA | Buy | CAREDX INC | $1,256,000 | -41.1% | 58,492 | +1.4% | 1.30% | -25.7% |
ATEC | Buy | ALPHATEC HLDGS INC | $1,233,000 | -38.6% | 188,500 | +8.0% | 1.28% | -22.4% |
FPAY | Buy | FLEXSHOPPER INC | $1,213,000 | -47.2% | 1,347,940 | +0.4% | 1.26% | -33.3% |
MGNI | Buy | MAGNITE INC | $1,208,000 | +288.4% | 136,025 | +478.2% | 1.25% | +390.2% |
Buy | ACHIEVE LIFE SCIENCES INC | $1,113,000 | -15.8% | 228,100 | +30.6% | 1.15% | +6.3% | |
ISR | Buy | ISORAY INC | $901,000 | -11.3% | 2,914,500 | +4.1% | 0.93% | +12.0% |
T | Buy | AT&T INC | $871,000 | -7.4% | 41,537 | +4.3% | 0.90% | +17.0% |
AKTS | Buy | AKOUSTIS TECHNOLOGIES INC | $836,000 | -33.9% | 225,950 | +16.2% | 0.86% | -16.5% |
Buy | JOURNEY MED CORP | $823,000 | -11.1% | 220,050 | +14.8% | 0.85% | +12.3% | |
AUGX | Buy | AUGMEDIX INC | $791,000 | -37.3% | 439,500 | +2.4% | 0.82% | -20.8% |
Buy | MDXHEALTH SAsponsored ads | $755,000 | +1.1% | 90,458 | +0.5% | 0.78% | +27.8% | |
FBIO | Buy | FORTRESS BIOTECH INC | $639,000 | +356.4% | 760,992 | +640.2% | 0.66% | +474.8% |
New | BIOLASE INC | $542,000 | – | 118,300 | +100.0% | 0.56% | – | |
AQB | Buy | AQUABOUNTY TECHNOLOGIES INC | $510,000 | -2.5% | 298,500 | +6.8% | 0.53% | +23.1% |
DCI | Buy | DONALDSON INC | $480,000 | -3.4% | 9,967 | +4.2% | 0.50% | +22.1% |
New | ROCKWELL MED INC | $458,000 | – | 355,052 | +100.0% | 0.47% | – | |
BLFS | Buy | BIOLIFE SOLUTIONS INC | $442,000 | -7.3% | 32,000 | +52.4% | 0.46% | +17.1% |
CSII | Buy | CARDIOVASCULAR SYS INC DEL | $362,000 | -34.5% | 25,200 | +3.1% | 0.38% | -17.2% |
AGFY | Buy | AGRIFY CORP | $353,000 | -37.2% | 179,185 | +47.7% | 0.36% | -20.8% |
KERN | New | AKERNA CORP | $300,000 | – | 2,173,000 | +100.0% | 0.31% | – |
TCMD | Buy | TACTILE SYS TECHNOLOGY INC | $241,000 | -29.5% | 32,967 | +94.3% | 0.25% | -11.1% |
VVOS | Buy | VIVOS THERAPEUTICS INC | $211,000 | -47.5% | 163,800 | +9.2% | 0.22% | -33.9% |
IRIX | Buy | IRIDEX CORP | $206,000 | -35.8% | 80,346 | +15.9% | 0.21% | -19.0% |
LUMN | Buy | LUMEN TECHNOLOGIES INC | $144,000 | +0.7% | 13,200 | +3.9% | 0.15% | +27.4% |
APYX | Buy | APYX MEDICAL CORPORATION | $127,000 | +89.6% | 21,600 | +109.7% | 0.13% | +138.2% |
VRAY | Buy | VIEWRAY INC | $115,000 | -11.5% | 43,500 | +31.0% | 0.12% | +11.2% |
New | SHARPS TECHNOLOGY INC | $91,000 | – | 94,500 | +100.0% | 0.09% | – | |
NBSE | Buy | NEUBASE THERAPEUTICS INC | $86,000 | -31.2% | 81,500 | +22.6% | 0.09% | -12.7% |
New | EROS MEDIA WORLD PLC | $60,000 | – | 25,000 | +100.0% | 0.06% | – | |
AMRN | Buy | AMARIN CORP PLCspons adr new | $52,000 | -36.6% | 35,000 | +40.0% | 0.05% | -19.4% |
SENS | Buy | SENSEONICS HLDGS INC | $47,000 | -7.8% | 45,500 | +75.0% | 0.05% | +16.7% |
ARAY | New | ACCURAY INC | $41,000 | – | 21,000 | +100.0% | 0.04% | – |
BHG | New | BRIGHT HEALTH GROUP INC | $18,000 | – | 10,000 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-07-29
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEOGENOMICS INC | 41 | Q3 2023 | 7.8% |
LILY ELI & CO | 41 | Q3 2023 | 6.9% |
PFIZER INC | 41 | Q3 2023 | 2.9% |
ATTUNITY LTD | 41 | Q3 2023 | 3.6% |
EXPEDITORS INTL WASH INC | 41 | Q3 2023 | 2.3% |
CVS HEALTH CORP | 41 | Q3 2023 | 1.6% |
DONALDSON INC | 41 | Q3 2023 | 1.3% |
VERIZON COMMUNICATIONS INC | 41 | Q3 2023 | 1.0% |
US BANCORP DEL | 41 | Q3 2023 | 0.8% |
BAXTER INTL INC | 40 | Q3 2023 | 14.1% |
View PERKINS CAPITAL MANAGEMENT INC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
BIOLASE, INC | May 15, 2023 | 689,196 | 2.1% |
FlexShopper, Inc. | February 09, 2023 | 1,281,460 | 5.9% |
Avinger Inc | February 14, 2020 | 891,761 | 5.2% |
Black Ridge Oil & Gas, Inc. | February 15, 2019 | 30,021,032 | 6.3% |
CANCER GENETICS, INC | February 15, 2019 | 1,135,250 | 4.0% |
TearLab Corp | February 15, 2019 | 1,666,294 | 13.1% |
Xtant Medical Holdings, Inc. | February 15, 2019 | 684,408 | 3.6% |
TearLab Corp | January 26, 2018 | 4,300,655 | 40.1% |
BIO KEY INTERNATIONAL INC | February 09, 2017 | 274,900 | 4.4% |
EnteroMedics Inc | February 09, 2017 | 1,455 | 0.0% |
View PERKINS CAPITAL MANAGEMENT INC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-09 |
13F-HR | 2024-01-22 |
13F-HR | 2023-11-02 |
13F-HR | 2023-07-21 |
SC 13G/A | 2023-05-15 |
13F-HR | 2023-05-09 |
SC 13G/A | 2023-02-09 |
SC 13G | 2023-02-09 |
13F-HR | 2023-01-26 |
13F-HR | 2022-10-24 |
View PERKINS CAPITAL MANAGEMENT INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.